Background: The transfusion-associated graft versus host disease (t-GvHD) occurring in immunosuppressed patients can be prevented by irradiation of red blood cell concentrates (RCCs) with gamma irradiation at a dose of 30 Gy prior to transfusion. The aim of this study was to investigate, whether the irradiation of leukocyte-depleted RCCs in different storage media (SAG-M, PAGGS-M, or Adsol) may cause deterioration of red blood cells (RBC), resulting in a shortened shelf life of the RCC. Material and Methods: According to manufacturing (manually, apheresis), storage medium used (SAG-M, PAGGS-M, Adsol) and processing of leukocyte depletion (filtered, nonfiltered), 192 RCCs were separated into 8 groups with 24 RCCs each. Each group was divided into two subgroups. One was irradiated (30 Gy), the other one was used as control. Until the end of shelf life, pH, the concentrations of Na+ , K+ , lactate, glucose, 2,3-diphosphoglycerate (2,3-DPG) and adenosine triphosphate (ATP), parameters of blood cell count, and external hemoglobin were measured every week. Results: The metabolic parameters did not show significant differences between nonirradiated and irradiated RCCs. K+ efflux and hemolysis were significantly higher in the irradiated RCCs after the first week of storage. The values of hemolysis remained below the recommended limit of 0.8% of the hemoglobin content of RCCs until the 28th day of storage. After 28 days of storage the mean values of K+ increased by 25% compared to the control samples at the end of shelf life. The mean corpuscular volume (MCV) was significantly higher in the irradiated RCCs with significant differences between the various storage media. Leukocyte-depleted RCCs showed partly smaller rates of hemolysis than unfiltered RCCs. Conclusions: The determined in vitro parameters of irradiated and leukocyte-depleted RCCs stored in SAG-M, PAGGS-M or Adsol revealed no significant quantitative changes until 28th day of storage compared to those of nonirradiated RCCs.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.